Attorneys

r. Alexander practices out of the New York office, where he focuses on securities fraud, corporate governance and shareholder rights litigation.   He is currently a member of the teams prosecuting securities claims against Merck and others arising from alleged misrepresentations concerning the safety profile of Merck's pain-killer, VIOXX.  Mr. Alexander also currently represents institutional investors in securities class actions alleging that Merck and Schering-Plough misrepresented and withheld the financially-devastating results of the ENHANCE drug trial, which seriously impugned the efficacy of the cholesterol-lowering drugs ZETIA and VYTORIN.

Prior to joining the firm, Mr. Alexander represented institutional clients in a number of high profile securities, corporate governance, and antitrust matters. 

Mr. Alexander was a member of his law school's award-winning national moot court team.  Following law school, Mr. Alexander served as a judicial clerk to Chief Justice Michael L. Bender of the Colorado Supreme Court.